Skip to content

Muscle Stimulation During DISE

The Effect of Palatoglossus and Genioglossus Stimulation During Drug-Induced Sleep Endoscopy

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03589846
Enrollment
60
Registered
2018-07-18
Start date
2018-07-26
Completion date
2028-12-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Drug-induced sleep endoscopy (DISE) is a widely used tool for assessing collapse patterns of the upper airway anatomy during sleep. Hypoglossal nerve stimulation therapy for obstructive sleep apnea suffers from variable response at the level of the soft palate. We propose a study examining the physiologic effect of palatoglossus and genioglossus muscle stimulation during DISE.

Detailed description

This is a single-arm study involving the use of a diagnostic device (muscle stimulator) that is not currently utilized in any clinical decision-making processes for OSA patients. All patients scheduled for DISE as part of their regular clinical care will be screened for enrollment via the previously described inclusion and exclusion criteria. The study is not blinded. No diagnostic information collected from muscle stimulation will be used in clinical decision-making processes.

Interventions

The Grass S88 nerve and muscle stimulator is a widely-used tool in electromyography and nerve conduction studies. Under anesthesia, fine-wire electrodes will be placed into the right genioglossus muscle (in the floor of the mouth) and the right palatoglossus muscle (in the anterior tonsillar pillar).

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

All patients who meet eligiblity will undergo muscle stimulation at the same time as the operative DISE procedure.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patient (≥18 years old) 2. A diagnosis of obstructive sleep apnea as determined by polysomnogram with an apnea-hypopnea index of ≥ 5.0/hr. 3. Intolerant of CPAP therapy due to physical or psychosocial limitations as determined by clinical history 4. Scheduled to undergo DISE as part of routine clinical assessment for further evaluation of pharyngeal anatomy

Exclusion criteria

1. Unable to consent for research due to a pre-existing neurologic condition as determined by PI 2. Unable to consent for research due to language barriers 3. A history of egg allergy as determined by history or self-reports 4. Currently pregnant as determined by patient report or pre-operative anesthesia evaluation 5. Cardiopulmonary or other medical conditions precluding safe propofol sedation as determined by pre-operative anesthesia evaluation 6. History of palatal or pharyngeal airway surgery including tonsillectomy as determined by clinical history and exam 7. History of radiation treatment to the head or neck as determined by history and/or physical exam

Design outcomes

Primary

MeasureTime frameDescription
Basic physiologic measurementsCollected during operative procedure, taking about 15 minutes.This study involves the collection of basic physiologic measurements (airway cross-sectional diameter with and without muscle stimulation) during a single session of DISE.

Secondary

MeasureTime frameDescription
Amount of current needed for adequate stimulationCollected during operative procedure, taking about 15 minutes.Obtain preliminary data regarding including the amount of current needed to adequately stimulate the palatoglossus muscle.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid T. Kent, MD

Vanderbilt University Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026